Index NDX, S&P 500
P/E 72.11
EPS (ttm) 5.54
Insider Own 0.69%
Shs Outstand 352.30M
Perf Week 4.03%
Market Cap 141.76B
Forward P/E 54.27
EPS next Y 7.36
Insider Trans -10.14%
Shs Float 352.27M
Perf Month 8.33%
Income 1.99B
PEG 5.74
EPS next Q 1.54
Inst Own 86.09%
Short Float 0.98%
Perf Quarter 5.11%
Sales 7.32B
P/S 19.37
EPS this Y 9.95%
Inst Trans -0.44%
Short Ratio 2.45
Perf Half Y 30.92%
Book/sh 39.36
P/B 10.15
EPS next Y 17.29%
ROA 13.76%
Short Interest 3.47M
Perf Year 27.44%
Cash/sh 13.53
P/C 29.53
EPS next 5Y 12.56%
ROE 15.79%
52W Range 254.85 - 403.76
Perf YTD 18.47%
Dividend Est. -
P/FCF 693.22
EPS past 5Y 9.71%
ROI 14.24%
52W High -1.02%
Beta 1.39
Dividend TTM -
Quick Ratio 4.61
Sales past 5Y 14.41%
Gross Margin 66.41%
52W Low 56.82%
ATR (14) 7.54
Dividend Ex-Date -
Current Ratio 5.55
EPS Y/Y TTM 52.08%
Oper. Margin 25.26%
RSI (14) 62.50
Volatility 1.74% 1.98%
Employees 13676
Debt/Eq 0.00
Sales Y/Y TTM 13.81%
Profit Margin 27.16%
Recom 2.00
Target Price 425.67
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 51.45%
Payout 0.00%
Rel Volume 0.86
Prev Close 400.03
Sales Surprise 1.09%
EPS Surprise 5.89%
Sales Q/Q 11.46%
Earnings Apr 18 AMC
Avg Volume 1.42M
Price 399.66
SMA20 4.35%
SMA50 3.81%
SMA200 18.30%
Trades
Volume 113,871
Change -0.09%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-17-23 Initiated
HSBC Securities
Buy
$318
Jul-19-23 Initiated
Robert W. Baird
Outperform
$377
Apr-19-23 Reiterated
Wells Fargo
Overweight
$289 → $310
Apr-19-23 Reiterated
Truist
Buy
$300 → $325
Apr-19-23 Reiterated
Stifel
Buy
$285 → $315
Apr-19-23 Reiterated
RBC Capital Mkts
Outperform
$305 → $309
Apr-19-23 Reiterated
Raymond James
Outperform
$270 → $323
Apr-19-23 Reiterated
Morgan Stanley
Equal-Weight
$265 → $285
Apr-19-23 Reiterated
JP Morgan
Overweight
$250 → $335
Apr-19-23 Reiterated
Evercore ISI
In-line
$240 → $270
Apr-19-23 Reiterated
Citigroup
Buy
$305 → $317
Apr-19-23 Reiterated
BTIG Research
Buy
$284 → $313
Apr-19-23 Reiterated
BofA Securities
Buy
$300 → $315
Mar-29-23 Initiated
UBS
Neutral
$278
Mar-23-23 Initiated
William Blair
Outperform
Oct-18-22 Initiated
Barclays
Overweight
$235
Oct-13-22 Initiated
Mizuho
Neutral
$215
Oct-12-22 Initiated
Jefferies
Hold
$210
Apr-13-22 Initiated
Truist
Buy
$360
Apr-06-22 Initiated
Wolfe Research
Peer Perform
$315
Show Previous Ratings
May-20-24 07:17PM
May-18-24 08:00AM
(Investor's Business Daily)
06:40AM
May-17-24 05:20PM
(Investor's Business Daily)
04:36PM
11:31AM
Loading…
11:31AM
06:24AM
May-15-24 10:15AM
May-14-24 11:31AM
10:00AM
07:00AM
05:21AM
May-13-24 12:06PM
May-10-24 04:26PM
May-09-24 03:45PM
01:04PM
Loading…
01:04PM
May-07-24 11:29AM
07:00AM
May-06-24 02:25PM
May-05-24 07:15AM
May-04-24 10:00AM
May-03-24 08:30AM
(Investor's Business Daily)
May-02-24 09:00AM
Apr-30-24 01:44PM
Apr-29-24 05:07PM
Apr-26-24 02:19PM
Apr-25-24 07:15PM
06:00AM
Apr-24-24 02:26PM
11:16AM
11:07AM
Loading…
Apr-23-24 11:07AM
Apr-22-24 09:00AM
Apr-20-24 01:03AM
Apr-19-24 04:13PM
(Investor's Business Daily)
03:13PM
10:55AM
10:08AM
(Investor's Business Daily)
08:15AM
07:59AM
07:00AM
(Thomson Reuters StreetEvents)
07:00AM
03:08AM
Apr-18-24 09:46PM
09:15PM
08:53PM
06:00PM
05:15PM
04:53PM
(Investor's Business Daily)
04:52PM
04:17PM
(Investor's Business Daily)
04:05PM
Apr-17-24 05:00PM
08:32AM
Apr-16-24 02:04PM
09:30AM
Apr-15-24 09:19AM
Apr-14-24 09:30AM
Apr-12-24 06:30AM
Apr-11-24 02:55PM
10:00AM
Apr-10-24 05:30PM
09:21AM
09:00AM
04:35AM
Apr-09-24 06:00PM
Apr-04-24 10:52AM
10:30AM
Apr-03-24 06:00PM
Apr-02-24 07:45AM
(Investor's Business Daily)
07:04AM
Apr-01-24 02:37PM
12:10PM
06:22AM
04:30AM
Mar-31-24 07:45AM
Mar-30-24 07:18AM
Mar-29-24 09:00AM
Mar-28-24 02:36PM
08:00AM
Mar-27-24 05:50PM
Mar-26-24 10:42AM
09:30AM
Mar-25-24 06:00PM
09:53AM
Mar-22-24 02:59PM
09:46AM
Mar-21-24 08:45AM
05:06AM
Mar-20-24 09:15AM
Mar-19-24 05:50PM
02:24PM
Mar-18-24 04:30PM
09:00AM
05:42AM
Mar-15-24 04:11PM
(Investor's Business Daily)
12:17PM
(Associated Press Finance)
10:42AM
(Investor's Business Daily)
10:09AM
09:41AM
Mar-14-24 05:16PM
(Investor's Business Daily)
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Brosius Mark SVP & Chief Mfg and Supply Cha May 17 '24 Sale 396.19 63 24,960 295 May 17 06:05 PM Miller Brian Edward EVP & Chief Digital Officer May 16 '24 Sale 400.00 2,553 1,021,200 9,619 May 17 04:33 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 16 '24 Sale 398.28 175 69,699 358 May 17 06:05 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 15 '24 Sale 387.22 175 67,764 533 May 15 05:39 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 14 '24 Sale 380.85 175 66,649 708 May 15 05:39 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 13 '24 Option Exercise 179.70 90 16,173 5,790 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 13 '24 Sale 389.16 284 110,521 5,506 May 14 04:57 PM Brosius Mark SVP & Chief Mfg and Supply Cha May 13 '24 Sale 389.16 175 68,103 883 May 15 05:39 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 11 '24 Option Exercise 0.00 360 0 5,867 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 10 '24 Option Exercise 267.19 239 63,858 5,627 May 14 04:57 PM DeSantis Robert EVP & Chief Strategy & Corp Op May 10 '24 Sale 385.55 239 92,146 5,507 May 14 04:57 PM RUBASH MARK J Director May 03 '24 Option Exercise 295.92 1,709 505,727 17,760 May 06 02:18 PM RUBASH MARK J Director May 03 '24 Sale 380.00 1,709 649,420 16,051 May 06 02:18 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 29 '24 Option Exercise 249.61 376 93,855 5,695 Apr 30 01:36 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 29 '24 Sale 375.39 376 141,147 5,507 Apr 30 01:36 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 26 '24 Option Exercise 273.00 1,498 408,950 5,903 Apr 30 01:36 PM DeSantis Robert EVP & Chief Strategy & Corp Op Apr 26 '24 Sale 369.92 1,498 554,146 5,507 Apr 30 01:36 PM Leonard Keith R Director Apr 25 '24 Option Exercise 0.00 569 0 1,606 Apr 26 03:44 PM Beery Joseph C Director Apr 25 '24 Option Exercise 0.00 569 0 2,371 Apr 26 03:09 PM BARRATT CRAIG H Director Apr 25 '24 Option Exercise 0.00 804 0 26,155 Apr 26 02:57 PM Reed Monica P Director Apr 25 '24 Option Exercise 0.00 569 0 1,606 Apr 26 02:47 PM LEVY ALAN J Director Apr 25 '24 Option Exercise 0.00 569 0 25,888 Apr 26 02:38 PM Ladd Amy L Director Apr 25 '24 Option Exercise 0.00 569 0 1,271 Apr 26 04:12 PM Johnson Amal M Director Apr 25 '24 Option Exercise 0.00 569 0 12,275 Apr 26 05:03 PM KANIA DON R Director Apr 25 '24 Option Exercise 0.00 569 0 3,838 Apr 26 08:08 PM Kolli Sreelakshmi Director Apr 25 '24 Option Exercise 0.00 240 0 240 Apr 26 08:34 PM NACHTSHEIM JAMI K Director Apr 25 '24 Option Exercise 0.00 569 0 5,632 Apr 26 08:41 PM RUBASH MARK J Director Apr 25 '24 Option Exercise 0.00 569 0 16,051 Apr 29 05:15 PM Curet Myriam EVP & Chief Medical Officer Apr 23 '24 Option Exercise 180.27 5,318 958,650 3,116 Apr 24 01:18 PM LEVY ALAN J Director Apr 23 '24 Option Exercise 154.24 2,000 308,473 27,319 Apr 24 02:22 PM Curet Myriam EVP & Chief Medical Officer Apr 23 '24 Sale 370.66 5,318 1,971,160 298 Apr 24 01:18 PM LEVY ALAN J Director Apr 23 '24 Sale 370.70 2,000 741,398 25,319 Apr 24 02:22 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Option Exercise 59.23 1,224 72,495 722 Mar 18 02:35 PM Widman Fredrik VP Corporate Controller Mar 15 '24 Sale 397.07 5,041 2,001,630 110 Mar 18 02:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Option Exercise 243.03 329 79,956 5,627 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 11 '24 Sale 390.16 329 128,363 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 11 '24 Sale 390.16 196 76,471 1,058 Mar 11 04:43 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Option Exercise 297.63 14,728 4,383,438 18,224 Mar 11 08:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Mar 08 '24 Sale 393.80 20,296 7,992,510 5,507 Mar 11 08:11 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 08 '24 Sale 392.02 196 76,836 1,254 Mar 11 04:43 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 07 '24 Sale 393.30 196 77,087 1,450 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 06 '24 Sale 386.76 196 75,805 1,646 Mar 07 05:17 PM Brosius Mark SVP & Chief Mfg and Supply Cha Mar 05 '24 Sale 400.00 196 78,400 1,842 Mar 07 05:17 PM Curet Myriam EVP & Chief Medical Officer Mar 01 '24 Sale 383.48 1,605 615,485 298 Mar 01 06:11 PM Curet Myriam EVP & Chief Medical Officer Feb 29 '24 Option Exercise 0.00 3,256 0 3,045 Feb 29 05:00 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 29 '24 Option Exercise 0.00 3,676 0 11,772 Feb 29 05:16 PM Rosa David J. President Feb 29 '24 Option Exercise 0.00 3,757 0 218,555 Feb 29 01:18 PM Widman Fredrik VP Corporate Controller Feb 29 '24 Option Exercise 0.00 1,317 0 4,094 Feb 29 01:04 PM Samath Jamie Chief Financial Officer Feb 29 '24 Option Exercise 0.00 2,006 0 9,139 Feb 29 07:48 PM GUTHART GARY S CEO Feb 29 '24 Option Exercise 0.00 6,370 0 16,629 Mar 01 01:01 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 29 '24 Option Exercise 0.00 1,843 0 2,483 Feb 29 07:38 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 29 '24 Option Exercise 0.00 2,201 0 23,824 Feb 29 06:56 PM Miller Brian Edward EVP & Chief Digital Officer Feb 29 '24 Option Exercise 0.00 2,817 0 13,028 Feb 29 07:26 PM MOHR MARSHALL Executive VP Global Business S Feb 29 '24 Option Exercise 0.00 3,256 0 50,150 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Option Exercise 142.35 129,810 18,478,437 58,397 Feb 29 07:17 PM MOHR MARSHALL Executive VP Global Business S Feb 28 '24 Sale 385.08 108,790 41,893,066 26,877 Feb 29 07:17 PM Curet Myriam EVP & Chief Medical Officer Feb 27 '24 Sale 386.46 843 325,786 298 Feb 27 03:58 PM Samath Jamie Chief Financial Officer Feb 26 '24 Option Exercise 0.00 1,284 0 8,197 Feb 27 03:26 PM Rosa David J. President Feb 26 '24 Option Exercise 0.00 1,710 0 216,807 Feb 27 03:19 PM MOHR MARSHALL Executive VP Global Business S Feb 26 '24 Option Exercise 0.00 1,710 0 27,744 Feb 27 03:35 PM Miller Brian Edward EVP & Chief Digital Officer Feb 26 '24 Option Exercise 0.00 1,650 0 11,432 Feb 27 03:49 PM Curet Myriam EVP & Chief Medical Officer Feb 26 '24 Option Exercise 0.00 1,710 0 2,008 Feb 27 03:58 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 26 '24 Option Exercise 0.00 855 0 1,564 Feb 27 04:16 PM Widman Fredrik VP Corporate Controller Feb 26 '24 Option Exercise 0.00 609 0 3,298 Feb 27 01:19 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 26 '24 Option Exercise 0.00 1,284 0 22,649 Feb 26 01:35 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 26 '24 Option Exercise 0.00 1,587 0 9,597 Feb 27 06:34 PM GUTHART GARY S CEO Feb 26 '24 Option Exercise 0.00 3,030 0 13,754 Feb 26 07:38 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 16 '24 Sale 378.29 32 12,105 709 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 15 '24 Sale 382.03 30 11,461 741 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 14 '24 Sale 380.09 30 11,403 771 Feb 16 05:51 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 13 '24 Sale 375.50 30 11,265 801 Feb 13 06:27 PM Curet Myriam EVP & Chief Medical Officer Feb 12 '24 Sale 386.09 481 185,709 298 Feb 13 12:29 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 12 '24 Sale 386.09 30 11,583 831 Feb 13 06:27 PM Curet Myriam EVP & Chief Medical Officer Feb 10 '24 Option Exercise 0.00 838 0 1,136 Feb 13 12:29 PM Widman Fredrik VP Corporate Controller Feb 10 '24 Option Exercise 0.00 568 0 2,911 Feb 12 02:11 PM DeSantis Robert EVP & Chief Strategy & Corp Op Feb 10 '24 Option Exercise 0.00 958 0 8,326 Feb 12 02:04 PM GUTHART GARY S CEO Feb 10 '24 Option Exercise 0.00 2,634 0 12,059 Feb 12 03:38 PM Samath Jamie Chief Financial Officer Feb 10 '24 Option Exercise 0.00 1,078 0 7,314 Feb 12 03:29 PM Charlton Henry L SVP & Chief Commercial and Mkt Feb 10 '24 Option Exercise 0.00 1,078 0 21,703 Feb 12 01:55 PM MOHR MARSHALL Executive VP Global Business S Feb 10 '24 Option Exercise 0.00 2,873 0 27,119 Feb 12 03:21 PM Miller Brian Edward EVP & Chief Digital Officer Feb 10 '24 Option Exercise 0.00 1,317 0 10,269 Feb 12 04:23 PM Brosius Mark See Remarks Feb 10 '24 Option Exercise 0.00 838 0 1,286 Feb 12 04:23 PM Rosa David J. President Feb 10 '24 Option Exercise 0.00 1,437 0 215,826 Feb 12 04:54 PM LOEB GARY General Counsel Feb 10 '24 Option Exercise 0.00 315 0 2,024 Feb 12 08:57 PM Rosa David J. President Feb 07 '24 Option Exercise 52.37 140,850 7,375,967 230,089 Feb 08 02:06 PM Rosa David J. President Feb 07 '24 Sale 389.28 80,710 31,418,468 163,399 Feb 08 02:06 PM Brosius Mark SVP & Chief Mfg and Supply Cha Feb 01 '24 Sale 378.41 39 14,758 448 Feb 05 05:15 PM GUTHART GARY S CEO Jan 29 '24 Option Exercise 51.02 33,750 1,721,776 33,750 Jan 30 04:28 PM GUTHART GARY S CEO Jan 29 '24 Sale 376.06 24,325 9,147,669 9,425 Jan 30 04:28 PM GUTHART GARY S CEO Jan 29 '24 Sale 374.41 4,960 1,857,074 27,360 Jan 30 04:28 PM Curet Myriam EVP & Chief Medical Officer Jan 26 '24 Option Exercise 179.67 4,318 775,816 3,007 Jan 29 05:32 PM Johnson Amal M Director Jan 26 '24 Option Exercise 56.97 6,696 381,501 18,402 Jan 29 05:25 PM LEVY ALAN J Director Jan 26 '24 Option Exercise 92.79 2,000 185,578 27,247 Jan 29 05:28 PM Johnson Amal M Director Jan 26 '24 Sale 370.08 6,696 2,478,032 11,706 Jan 29 05:25 PM Curet Myriam EVP & Chief Medical Officer Jan 26 '24 Sale 370.15 4,318 1,598,298 189 Jan 29 05:32 PM LEVY ALAN J Director Jan 26 '24 Sale 370.20 2,000 740,405 25,319 Jan 29 05:28 PM Curet Myriam EVP & Chief Medical Officer Nov 16 '23 Option Exercise 173.01 8,819 1,525,799 4,689 Nov 17 03:00 PM Johnson Amal M Director Nov 16 '23 Option Exercise 41.26 9,567 394,713 21,273 Nov 17 03:11 PM Johnson Amal M Director Nov 16 '23 Sale 300.00 9,567 2,870,100 11,706 Nov 17 03:11 PM Curet Myriam EVP & Chief Medical Officer Nov 16 '23 Sale 300.00 8,819 2,645,700 189 Nov 17 03:00 PM
Index -
P/E -
EPS (ttm) -0.92
Insider Own 2.91%
Shs Outstand 191.38M
Perf Week -3.11%
Market Cap 314.91M
Forward P/E -
EPS next Y -0.76
Insider Trans -2.25%
Shs Float 178.28M
Perf Month 26.10%
Income -175.84M
PEG -
EPS next Q -0.20
Inst Own 59.65%
Short Float 1.99%
Perf Quarter 148.55%
Sales 90.17M
P/S 3.49
EPS this Y 44.31%
Inst Trans -4.28%
Short Ratio 1.38
Perf Half Y 256.18%
Book/sh 0.69
P/B 2.49
EPS next Y 5.57%
ROA -36.72%
Short Interest 3.54M
Perf Year 137.60%
Cash/sh 1.58
P/C 1.09
EPS next 5Y -7.30%
ROE -95.68%
52W Range 0.41 - 1.93
Perf YTD 203.54%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -51.83%
52W High -11.05%
Beta 0.79
Dividend TTM -
Quick Ratio 5.79
Sales past 5Y -20.42%
Gross Margin 60.91%
52W Low 315.66%
ATR (14) 0.14
Dividend Ex-Date -
Current Ratio 6.10
EPS Y/Y TTM 58.37%
Oper. Margin -147.13%
RSI (14) 59.18
Volatility 5.27% 9.04%
Employees 137
Debt/Eq 1.83
Sales Y/Y TTM 1.51%
Profit Margin -195.02%
Recom 3.00
Target Price 1.60
Option/Short Yes / Yes
LT Debt/Eq 1.68
EPS Q/Q 73.95%
Payout -
Rel Volume 0.36
Prev Close 1.75
Sales Surprise 41.05%
EPS Surprise 0.00%
Sales Q/Q 0.21%
Earnings May 09 AMC
Avg Volume 2.56M
Price 1.72
SMA20 7.00%
SMA50 31.22%
SMA200 120.99%
Trades
Volume 87,315
Change -2.00%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-20-23 Resumed
JP Morgan
Underweight
Nov-09-23 Upgrade
TD Cowen
Market Perform → Outperform
May-10-23 Upgrade
Jefferies
Underperform → Hold
$1.50 → $1
Feb-24-23 Downgrade
Jefferies
Hold → Underperform
$3.20 → $1.50
Aug-08-22 Downgrade
JP Morgan
Neutral → Underweight
May-31-22 Resumed
Jefferies
Hold
$12 → $4
Apr-18-22 Downgrade
Goldman
Neutral → Sell
$3
Mar-15-22 Downgrade
Mizuho
Buy → Neutral
$35 → $8
Mar-15-22 Downgrade
Cowen
Outperform → Market Perform
Mar-14-22 Downgrade
William Blair
Outperform → Mkt Perform
Mar-14-22 Downgrade
Stifel
Buy → Hold
$24 → $5
Mar-14-22 Downgrade
BTIG Research
Buy → Neutral
Mar-14-22 Downgrade
BofA Securities
Neutral → Underperform
$18 → $6
Mar-09-22 Upgrade
Oppenheimer
Perform → Outperform
$21
Nov-08-21 Upgrade
The Benchmark Company
Hold → Buy
$20
Sep-10-21 Initiated
BofA Securities
Neutral
$18
Jun-28-21 Upgrade
Stifel
Hold → Buy
$22 → $24
May-18-21 Resumed
Goldman
Neutral
$24
Feb-22-21 Downgrade
The Benchmark Company
Buy → Hold
Jan-06-21 Initiated
Stifel
Hold
$18
Show Previous Ratings
May-10-24 04:41PM
03:14PM
11:33AM
10:35AM
(Thomson Reuters StreetEvents)
May-09-24 05:39PM
(Associated Press Finance)
04:15PM
Loading…
04:15PM
May-02-24 06:00PM
Apr-03-24 11:30AM
Mar-25-24 10:00AM
Mar-22-24 02:00PM
Mar-06-24 12:33PM
Mar-05-24 10:07AM
09:13AM
09:00AM
07:19AM
(Thomson Reuters StreetEvents)
05:30PM
Loading…
Mar-04-24 05:30PM
04:51PM
04:42PM
(Associated Press Finance)
04:15PM
08:30AM
Feb-27-24 06:00PM
Feb-26-24 06:00PM
Feb-20-24 10:00AM
Jan-03-24 06:00PM
Dec-11-23 06:00PM
Dec-07-23 11:31AM
Nov-09-23 08:39AM
Nov-08-23 11:47AM
Nov-07-23 05:28PM
(Associated Press Finance)
04:15PM
06:00PM
Loading…
Oct-31-23 06:00PM
Oct-26-23 10:02AM
Oct-23-23 10:08AM
Oct-13-23 08:30AM
Oct-02-23 09:00AM
Sep-27-23 09:00AM
Sep-14-23 07:54AM
Sep-13-23 09:00AM
Sep-07-23 11:31AM
Sep-06-23 06:00PM
Aug-17-23 07:02PM
Aug-09-23 09:25AM
Aug-08-23 05:30PM
04:23PM
04:15PM
11:08AM
(American City Business Journals)
Aug-07-23 10:23AM
06:30AM
Aug-01-23 06:00PM
Jul-24-23 03:48AM
Jul-16-23 08:49AM
Jun-12-23 06:00PM
Jun-08-23 12:55PM
11:31AM
May-10-23 11:28AM
09:16AM
May-09-23 06:45PM
05:41PM
04:15PM
May-08-23 09:29AM
May-04-23 10:00AM
May-02-23 10:01AM
Apr-27-23 08:30AM
Apr-19-23 08:38AM
Apr-17-23 05:00PM
Apr-16-23 06:30AM
Apr-13-23 10:59AM
Apr-11-23 08:57AM
Apr-10-23 10:07AM
Apr-02-23 08:27AM
Mar-30-23 11:30AM
Mar-29-23 05:44PM
Mar-24-23 12:00PM
Mar-22-23 09:35AM
Mar-14-23 03:43AM
Feb-28-23 05:15PM
Feb-24-23 10:23AM
07:29AM
Feb-23-23 06:20PM
05:24PM
04:30PM
Jan-09-23 09:04AM
Jan-04-23 09:00AM
Dec-12-22 10:05AM
Dec-05-22 08:00AM
Nov-10-22 09:05AM
07:58AM
Nov-09-22 09:00AM
Nov-04-22 12:35PM
Nov-03-22 06:35PM
Oct-28-22 10:00AM
Oct-27-22 10:02AM
Oct-25-22 06:00PM
Oct-24-22 07:55AM
Oct-11-22 05:13PM
(American City Business Journals)
Oct-07-22 03:42PM
(American City Business Journals)
11:21AM
Sep-07-22 01:15AM
Aug-21-22 09:57AM
Aug-16-22 08:30AM
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROBIN HOWARD W President & CEO May 17 '24 Sale 1.75 16,650 29,138 863,239 May 20 09:14 PM Zalevsky Jonathan Chief R&D Officer May 17 '24 Sale 1.75 7,355 12,871 257,670 May 20 09:13 PM Wilson Mark Andrew Chief Legal Officer May 17 '24 Sale 1.75 6,260 10,955 230,414 May 20 09:12 PM Deep Track Capital, LP 10% Owner May 10 '24 Sale 1.78 56,000 99,630 18,344,000 May 13 04:36 PM ROBIN HOWARD W President & CEO Feb 20 '24 Sale 0.68 20,033 13,622 879,889 Feb 22 08:16 PM Zalevsky Jonathan Chief R&D Officer Feb 20 '24 Sale 0.68 9,014 6,130 265,025 Feb 22 08:19 PM Wilson Mark Andrew Chief Legal Officer Feb 20 '24 Sale 0.68 7,606 5,172 236,674 Feb 22 08:17 PM ROBIN HOWARD W President & CEO Nov 17 '23 Sale 0.49 19,877 9,740 899,922 Nov 20 08:58 PM Zalevsky Jonathan Chief R&D Officer Nov 17 '23 Sale 0.49 9,646 4,727 274,039 Nov 20 09:02 PM Wilson Mark Andrew Chief Legal Officer Nov 17 '23 Sale 0.49 7,179 3,518 243,780 Nov 20 09:00 PM Curet Myriam Director Sep 18 '23 Sale 0.69 4,359 3,008 27,418 Sep 20 08:09 PM Ajer Jeffrey Robert Director Sep 18 '23 Sale 0.69 4,359 3,008 34,153 Sep 20 08:06 PM ROBIN HOWARD W President & CEO Aug 16 '23 Sale 0.78 19,998 15,598 919,799 Aug 17 08:06 PM Zalevsky Jonathan Chief R&D Officer Aug 16 '23 Sale 0.78 9,703 7,568 283,685 Aug 17 08:08 PM Wilson Mark Andrew Chief Legal Officer Aug 16 '23 Sale 0.78 7,221 5,632 250,959 Aug 17 08:07 PM WHITFIELD ROY A Director Jun 14 '23 Sale 0.57 30,000 17,100 216,250 Jun 15 06:26 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite